Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion-Reference-Cited by-同舟云学术

Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion

Published:2021-05-14 Issue:6 Volume:11 Page:1771-1784
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:FEBS Open Bio

Author:

Chen Jintu¹^ORCID,Chen Canwei²,Lin Yongfa³,Su Yongfa¹,Yu Xueping¹,Jiang Yancheng¹,Chen Zixuan¹,Ke ShaoYing¹,Lin ShaoZe¹,Chen LiangJuan¹,Zhang Zhishan¹,Zhang Tao⁴

Affiliation:

1. Department of Clinical Laboratory Quanzhou First Hospital Affiliated to Fujian Medical University China

2. Department of Clinical Laboratory The Hospital of Nanan City China

3. Department of Clinical laboratory Yongchun Hospital of Traditional Chinese Medicine China

4. Department of Immunology School of Basic Medical Sciences Fujian Medical University Fuzhou China

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.13173

Reference43 articles.

1. Hepatocellular carcinoma

2. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications

3. Management of hepatocellular carcinoma: An update

4. Precision diagnosis and treatment of liver cancer in China

5. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel model based on lipid metabolism-related genes associated with immune microenvironment predicts metastasis of breast cancer;Discover Oncology;2024-08-27

2. Expression of SUMO and NF-κB genes in hepatitis B virus-associated hepatocellular carcinoma patients: An observational study;Medicine;2024-06-28

3. FEN1 upregulation mediated by SUMO2 via antagonizing proteasomal degradation promotes hepatocellular carcinoma stemness;Translational Oncology;2024-06

4. Abnormal protein SUMOylation in liver disease: novel target for therapy;Journal of Molecular Medicine;2024-04-03

5. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer;Cell Reports;2024-03